Death but one unintended consequence of gene-therapy trial.
Year: 2001
Type: article
Abstract: Jesse Gelsinger wanted to help others overcome the same metabolic disorder he had, so he agreed to enter a gene-therapy trial. A short time later, the 18-year-old American became the first person to die because of participation in gene-therapy research.
His death would be but one of several
Source: Europe PMC (PubMed Central)
Author: B Sibbald
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W1584452806
